Talampanel
Talampanel (LY300164) is an orally and selective α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor antagonis with anti-seizure activity[1]. Talampanel (IVAX) has neuroprotective effects in rodent stroke models[2]. Talampanel attenuates caspase-3 dependent apoptosis in mouse brain[2].
Product Specifications
CAS Number
161832-65-1
Product Name Alternative
GYKI-53773; LY-300164
UNSPSC
12352005
Hazard Statement
H301, H401
Target
Apoptosis; iGluR
Type
Reference compound
Related Pathways
Apoptosis; Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/Talampanel.html
Concentration
10mM
Purity
99.77
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C[C@@H]1CC2=C(C=C(OCO3)C3=C2)C(C4=CC=C(N)C=C4)=NN1C(C)=O
Molecular Formula
C19H19N3O3
Molecular Weight
337.37
Precautions
H301, H401
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
AMPA Receptor
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Treponema pallidum (Syphillis) (HRP) discontinued
Anti-Mouse CTLA-4 (UC10-4F10-11) In Vivo Antibody - Low Endotoxin
EEGV1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
5HT7 Receptor Recombinant Antibody, HRP Conjugated
Cyclin D1 (G1-Cyclin & Mantle Cell Lymphoma Marker) ; Clone CCND1/3370R (Concentrate)